Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -0.132M
March 31, 2026 -0.05M
December 31, 2025 -0.075M
September 30, 2025 -0.054M
June 30, 2025 -0.059M
March 31, 2025 -0.138M
December 31, 2024 -0.044M
September 30, 2024 -0.109M
June 30, 2024 -0.07M
March 31, 2024 0.00
December 31, 2023 -0.049M
September 30, 2023 -0.023M
June 30, 2023 -0.032M
March 31, 2023 -0.022M
December 31, 2022 -0.052M
September 30, 2022 -0.119M
June 30, 2022 -0.096M
March 31, 2022 -0.01M
December 31, 2021 -0.058M
September 30, 2021 -0.303M
June 30, 2021 -0.136M
March 31, 2021 -0.185M
December 31, 2020 -0.03M
September 30, 2020 -0.056M
June 30, 2020 0.014M
Date Value
March 31, 2020 -0.024M
December 31, 2019 -0.006M
September 30, 2019 -0.019M
June 30, 2019 -0.027M
March 31, 2019 -0.003M
December 31, 2018 -0.031M
September 30, 2018 -0.022M
June 30, 2018 -0.039M
March 31, 2018 -0.005M
December 31, 2017 -0.143M
September 30, 2017 0.00
June 30, 2017 0.101M
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.026M
March 31, 2016 -0.026M
December 31, 2015 0.166M
September 30, 2015 1.861M
June 30, 2015 -0.24M
March 31, 2015 0.00
December 31, 2014 0.152M
September 30, 2014 3.645M
June 30, 2014 -0.079M
March 31, 2014 -0.093M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
NeoGenomics, Inc. -8.319M
Quest Diagnostics, Inc. -134.00M
Labcorp Holdings, Inc. -366.20M
OPKO Health, Inc. 15.54M
Psychemedics Corp. --